Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← All grants

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

fromNational Library of Medicine (NLM), National Institutes of Health (NIH)openone off
Deadline
March 5, 2029
in 901 days
Amount
$2,500,000 total program funding; 10 expected awards; award maximum $250,000.
About this grant

The National Library of Medicine seeks applications for R01 research projects that drive groundbreaking innovation and advanced development in bioinformatics, translational bioinformatics, and computational biology. Clinical trials are optional.

Eligibility

Nonprofits, governments, higher education institutions, small businesses, for-profit organizations, and certain foreign organizations/components are eligible, subject to NIH NOFO rules.

Instructions & requirements
Deadline

The standard due date for new applications is June 5, 2026.

Deadline

The standard due date for renewal, resubmission, or revision applications, as allowed, is July 5, 2026.

Deadline

The standard due date for new applications in the next review cycle is October 5, 2026.

Deadline

The standard due date for renewal, resubmission, or revision applications, as allowed, in the next review cycle is November 5, 2026.

Deadline

The funding opportunity expires on March 6, 2029.

Official documentlanding pagelanding page
Key People
NLM Extramural ProgramsGrantor contact / program contact
Contacts (1)
NameRoleLinkedInTwitter
NLM Extramural ProgramsGrantor contact / program contact
Apply for this grant →More info ↗